Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons

Background. Antiretroviral preexposure prophylaxis (PrEP), using daily oral combination tenofovir disoproxil fumarate plus emtricitabine, is an effective human immunodeficiency virus (HIV) prevention strategy for populations at high risk of HIV acquisition. Although the primary mode of action for th...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Infect Dis
Main Authors: Pattacini, Laura, Murnane, Pamela M., Baeten, Jared M., Fluharty, Tayler R., Thomas, Katherine K., Bukusi, Elizabeth, Katabira, Elly, Mugo, Nelly, Donnell, Deborah, Lingappa, Jairam R., Celum, Connie, Marzinke, Mark, McElrath, M. Juliana, Lund, Jennifer M.
格式: Artigo
語言:Inglês
出版: Oxford University Press 2015
主題:
Major Articles and Brief Reports
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4836720/
https://ncbi.nlm.nih.gov/pubmed/25520426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu815
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍